Fact based stock research
West Pharmaceutical Services (NYSE:WST)


West Pharmaceutical Services stock research in summary

westpharma.com


West Pharmaceutical Services shares have a HOLD rating. While they are safely financed, they show below average growth, and are bad value. We recommend holding West Pharmaceutical Services shares.


Latest Obermatt Ranks


Country USA
Industry Health Care Supplies
Index S&P MIDCAP, D.J. US Medical Equipment
Size class Medium

June 8, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Achievements

Top 10 Stock



Research History: West Pharmaceutical Services

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
40
29
23
32
STOCK GROWTH RANKS
36
96
40
38
STOCK SAFETY RANKS
73
69
95
76
COMBINED STOCK RANKS
31
71
76
57

Last update of Combined Rank: 8-Jun-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is West Pharmaceutical Services in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 8-Jun-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of West Pharmaceutical Services; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
35
65
34
37
PROFIT GROWTH
43
43
43
33
STOCK RETURNS
54
95
55
52
CONSOLIDATED RANK: GROWTH
36
96
40
38

Financial reporting date of Growth Rank: 31-Mar-2018. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of West Pharmaceutical Services.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
50
50
58
50
REFINANCING
27
26
28
32
LIQUIDITY
92
95
97
100
CONSOLIDATED RANK: SAFETY
73
69
95
76

Financial reporting date of Safety Rank: 31-Mar-2018. Stock analysis on safety metrics: The higher the rank, the lower the leverage of West Pharmaceutical Services and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for West Pharmaceutical Services from June 8, 2018.